Inactivated Poliomyelitis vaccine — Competitive Intelligence Brief

Inactivated Poliomyelitis vaccine (Inactivated Poliomyelitis vaccine) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Inactivated viral vaccine. Area: Immunology / Infectious Disease.

phase 3 Inactivated viral vaccine Immunology / Infectious Disease Biologic

Target snapshot

Inactivated Poliomyelitis vaccine (Inactivated Poliomyelitis vaccine) — Sanofi Pasteur, a Sanofi Company. Inactivated poliomyelitis vaccine stimulates the immune system to produce antibodies against all three serotypes of poliovirus, providing protection against polio infection.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Inactivated Poliomyelitis vaccine TARGET	Inactivated Poliomyelitis vaccine	Sanofi Pasteur, a Sanofi Company	phase 3	Inactivated viral vaccine
Hepatitis A vaccine	Hepatitis A vaccine	MacroGenics	marketed	inactivated viral vaccine	Hepatitis A virus surface antigens
Havrix 720 Junior	Havrix 720 Junior	Chiang Mai University	marketed	Inactivated viral vaccine	Hepatitis A virus surface antigen
IPV-Al	IPV-Al	AJ Vaccines A/S	marketed	Inactivated viral vaccine	Poliovirus serotypes 1, 2, and 3
EV71 inactived vaccine（Vero cells）	EV71 inactived vaccine（Vero cells）	Sinovac Biotech Co., Ltd	marketed	inactivated viral vaccine	Enterovirus 71 (EV71) viral antigens
fIPV (0.1mL) IM	fIPV (0.1mL) IM	Centers for Disease Control and Prevention	marketed	inactivated viral vaccine	poliovirus serotypes 1, 2, and 3
EV71 Vaccine only	EV71 Vaccine only	Sinovac Biotech Co., Ltd	marketed	Inactivated viral vaccine	Enterovirus 71 (EV71) viral antigens

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Inactivated viral vaccine class)

1. Sinovac Biotech Co., Ltd · 9 drugs in this class
2. Sanofi Pasteur, a Sanofi Company · 9 drugs in this class
3. GlaxoSmithKline · 5 drugs in this class
4. Valneva Austria GmbH · 4 drugs in this class
5. Medical University of Vienna · 3 drugs in this class
6. Centers for Disease Control and Prevention · 3 drugs in this class
7. China National Biotec Group Company Limited · 2 drugs in this class
8. Statens Serum Institut · 2 drugs in this class
9. Institute of Medical Biology, Chinese Academy of Medical Sciences · 2 drugs in this class
10. Crucell Holland BV · 2 drugs in this class